LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Cross reactivity of commercial anti‐dengue immunoassays in patients with acute Zika virus infection

Photo from wikipedia

Several countries have local transmission of multiple arboviruses, in particular, dengue and Zika viruses, which have recently spread through many American countries. Cross reactivity among Flaviviruses is high and present… Click to show full abstract

Several countries have local transmission of multiple arboviruses, in particular, dengue and Zika viruses, which have recently spread through many American countries. Cross reactivity among Flaviviruses is high and present a challenge for accurate identification of the infecting agent. Thus, we evaluated the level of cross reactivity of anti‐dengue IgM/G Enzyme‐Linked Immunosorbent Assays (ELISA) from three manufacturers against 122 serum samples obtained at two time‐points from 61 patients with non‐dengue confirmed Zika virus infection. All anti‐dengue ELISAs cross reacted with serum from patients with acute Zika infection at some level and a worrisome number of seroconversion for dengue IgG and IgM was observed. These findings may impact the interpretation of currently standard criteria for dengue diagnosis in endemic regions.

Keywords: dengue; cross reactivity; infection; anti dengue

Journal Title: Journal of Medical Virology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.